“Vioftan-4” is recommended for use in retinitis pigmentosa, macular dystrophy, retinopathy, hemeralopia (chicken blindness).
Active action of “Vioftan-4”:
- Restoration of the function of retinal pigment cells.
- Restoration of photoreceptor function.
- Protection of the interfotoreceptor matrix.
- Protective effect on cellular sources of retinal regeneration.
1 ml of a sterile solution contains; 0.1±0.01 mg of CaCI2 and 10-10-10-11 mg of a protein-peptide complex.
“Vioftan-4” supports the viability of pigment epithelial cells, their adhesive interactions in the retinal monolayer. Activates cellular sources of regeneration in the retina — in particular, the cells of the Muller glia and bipolars, thereby ensuring the spatial and functional organization of the interphotoreceptor space.
Recommendations for use:
For the prevention and treatment of traumatic injuries, retinal dystrophy, retinitis pigmentosa, the initial stage of macular dystrophy of the eye.
Method of application:
1-2 drops of the solution should be installed on the eyelid from three to five times a day, depending on the intensity of turbidity.
Discontinuation of the drug is recommended after the disappearance of negative sensations.
In a clean, dry, protected from the sun place at a temperature of +5 to +25 °C and a relative humidity of not more than 75%.
2 years from the date of manufacture. After opening, store in the refrigerator and use for 30 days.